Clinical Trials Logo

Lung Cancer clinical trials

View clinical trials related to Lung Cancer.

Filter by:

NCT ID: NCT05337163 Completed - Lung Cancer Clinical Trials

A Multicenter Clinical Trial of Sputum DNA Testing for Lung Cancer in China

Start date: February 25, 2022
Phase:
Study type: Observational

The primary objective of this study is to assess the safety and effectiveness of Human Multigene Methylation Detection Kit (Fluorescent PCR Method) for help diagnose lung cancer by comparing with clinical standard method (includes chest CT examination or pathological examination).

NCT ID: NCT05332925 Recruiting - Lung Cancer Clinical Trials

Using Ex Vivo Tumoroids To Predict Immunotherapy Response In NSCLC

TUMORIN
Start date: July 21, 2022
Phase:
Study type: Observational

To test whether it is feasible to perform the 3D-EX functional predictive response bioassay in the context of patients with advanced/metastatic NSCLC receiving immune checkpoint inhibitors in the standard of care clinical setting.

NCT ID: NCT05332171 Not yet recruiting - Lung Cancer Clinical Trials

Examination Of Exercise Adherence İn Lung Cancer Patients Given Calisthenic Exercise

Start date: April 2022
Phase: N/A
Study type: Interventional

Cancer treatments usually include surgery, chemotherapy, radiation therapy, hormone therapy, and/or a combination of these methods. These treatments cause many physical and psychological effects that interfere with functional independence, performing activities of daily living, and healthy quality of life. Mostly, depending on cancer and its treatment; Cognitive function, sleep pattern, functional capacity, pain state and bone mineral density are affected. Exercise compliance is the degree to which an individual's behavior is consistent with the health care provider's advice and treatment plan. According to the World Health Organization, compliance is "a measure of a person's behavior (such as following a recommended exercise program, monitoring drug intake, etc.). ) as a response to complying with recommendations deemed appropriate by health care professionals''. In the field of rehabilitation too, compliance is increasingly used in relation to the self-management of patients' health. It has been stated in the studies that the level of compliance with the recommended home exercise is generally low, which limits the benefits of exercise programs.

NCT ID: NCT05331391 Recruiting - Lung Cancer Clinical Trials

A Mobile SMART Exercise Support Program to Improve Fatigue in Lung Cancer Patients - A RCT

Start date: May 1, 2022
Phase: N/A
Study type: Interventional

Lung cancer (LC) is a common cancer in the world. Among all symptoms, Fatigue is considered as the most distressing medical condition of LC. Prior studies revealed that physical activity effectively relieve fatigue and related problems. The current study attempt to explore the effectiveness of SMART Exercise Support Program (SES) with the use of mobile instant messaging application, on reducing symptoms such as fatigue, and improving physical activity level, physical fitness performance, sleep quality and habits, and quality of life in advanced lung cancer (ALC) patients.

NCT ID: NCT05329402 Completed - Lung Cancer Clinical Trials

Disposable Powered Articulating Linear Cutter Stapler in Total-Thoracoscopic Anatomic Lobectomy (Segmentectomy)

Start date: October 22, 2018
Phase: N/A
Study type: Interventional

To evaluate whether the anastomosis success rate of the main effectiveness evaluation indexes is not inferior to the similar products produced by Johnson & Johnson when the Fengh Disposable Powered Articulating Endoscopic Linear Cutter Stapler Used for Thoracoscopic Anatomic Lobectomy (segmentectomy)

NCT ID: NCT05326906 Completed - Lung Cancer Clinical Trials

The Prediction Biomarkers of Survival Outcome for Severe Immune-related Hepatitis

Start date: May 1, 2018
Phase:
Study type: Observational

Immune checkpoint inhibitors have revolutionized lung cancer (LC) treatment, demonstrating a significant improvement in overall survival. However high-grade immune-related adverse events (irAEs) may result in harmful and serious clinical outcomes, even death. Immune-related hepatitis (IRH) is a potentially serious complication of checkpoint blockade, with an incidence of 5%-10% for ICIs monotherapy, including 1%-2% with grade 3 or higher. Therefore, it is particularly important to explore new and better prognostic and predictive biomarkers for IRH.

NCT ID: NCT05321615 Not yet recruiting - Lung Cancer Clinical Trials

Feasibility and Safety of a Wireless Palpator

Palpator
Start date: March 1, 2024
Phase: N/A
Study type: Interventional

Evaluation of the ability of the Palpator to detect hidden (occult) lung tumours that cannot be visualized or palpated using the traditional methods of visual inspection, grasper palpation, and VATS ultrasound.

NCT ID: NCT05320458 Not yet recruiting - Lung Cancer Clinical Trials

Pulmonary Rehabılıtatıon Wıth Non-Small Lung Cancer

Start date: May 2, 2022
Phase: N/A
Study type: Interventional

The aim of our study is to investigate the effects of pulmonary rehabilitation on respiratory tests and quality of life in patients with early and locally advanced NSCLC who received chemotherapy regardless of whether the investigators had undergone surgical treatment.

NCT ID: NCT05319886 Recruiting - Lung Cancer Clinical Trials

Observational Study of the Efficacy and Safety of Anlotinib Combined With Penpulimab in Elderly Lung Cancer Patients

AP
Start date: May 16, 2022
Phase:
Study type: Observational [Patient Registry]

This prospective observational study will evaluate the efficacy and safety of anlotinib in combination with Penpulimab in elderly patients with lung cancer. Data will be collected from each patient at baseline and after 4-6 cycles of therapy.

NCT ID: NCT05319457 Completed - Lung Cancer Clinical Trials

Testing Radon Com Methods: Clinical Trial Smartphone App vs Print Brochures

Start date: May 5, 2022
Phase: N/A
Study type: Interventional

The purpose of this research study is to compare the effectiveness of radon information delivered via the radon app vs. a traditional approach (printed brochure). The prevalence of exceptionally high levels of residential radon in ND, coupled with public's poor understanding of this hazard, is a critical public health problem.